Ethical dilemmas in pediatric endocrinology: Growth hormone for short normal children

R. Macklin

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Ethical questions surrounding the administration of synthetic growth hormone (GH) to short normal children can be grouped into the following four categories: 1) appropriateness of medical treatment when no disease or biological deficiency is present; 2) how to proceed in the face of ambiguity or uncertainty of research results; 3) difficulty in weighing the risks and benefits of treatment; and 4) who should decide? This article seeks to determine whether GH administration to normal short children is properly considered an 'enhancement', and, if so, whether such treatment would be ethically wrong.

Original languageEnglish (US)
Pages (from-to)1349-1352
Number of pages4
JournalJournal of Pediatric Endocrinology and Metabolism
Volume13
Issue numberSUPPL. 6
StatePublished - Dec 1 2000

Keywords

  • Enhancement
  • Ethical considerations
  • Growth hormone
  • Moral
  • Short children

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Ethical dilemmas in pediatric endocrinology: Growth hormone for short normal children'. Together they form a unique fingerprint.

  • Cite this